19 - Carcinogenesis and Skin Flashcards
Combined incidence of SCC and BCC is likely to be at least _____fold higher than that of all other cancers combined
Two
Whereas single base mutations in early SCC lesions frequently are characteristic of _____-induced damage, later changes are associated with _____
UV light
Genomic instability
_____ mutations are characteristic of chemical mutagens used to initiate tumor formation
Ras
Most events occur early in the progression sequence in (UV-induced tumors/chemical carcinogenesis), but in (UV-induced tumors/chemical carcinogenesis), most events occur late and often do not bear the signatures of the original mutagen
UV-induced tumors
Chemical carcinogenesis
A driving force underlying neoplastic progression is ______, which enables the accumulation of mutations involving oncogenes and tumor suppressor genes that contribute to the observed abberations in tumor cell function
Defective DNA repair
Tumors contain a small number of self-renewing stem cells that produce transient-amplifying and differentiating progeny
Cancer stem cells or
Tumor-initiating cells
Constitute the overwhelming majority if cells in a tumor
Transient-amplifying and differentiating progeny
Y/N: Transformation of different cell populations produces different tumor subtypes, so a tumor’s cell of origin is a key determinant of its ultimate phenotype
Yes
Any gene that can transform normal cells in culture and induce cancer in animals
Oncogene
Most oncogenes are derived from
Proto-oncogenes
Negatively regulate cell proliferation, cause apoptosis, repair damaged DNA, or induce cellular differentation
Tumor suppressor genes
In contrast to (oncogenes/tumor suppressor genes), which typically require that only one allele undergo activation via mutation, both alleles of (oncogenes/tumor suppressor genes) must be inactivated to promote tumor development
Oncogenes
Tumor suppressor genes
Markedly increased risk of developing BCCs which arise at a younger age and appear in greater numbers
Predisposed to the development of a pediatric brain tumor arising in the cerebellum, medulloblastoma, as well as a variety of other defects throughout the body, including bifid ribs, calcified falx cerebri, odontogenic keratocysts, frontal bossing, palmar pits
Nevoid BCC syndrome
NBCCS is caused by germline mutations disrupting the
PTCH1 gene
Deregulated activity of the ______ pathway is detected in essentially all BCCs
Hedgehog
Inherited cancer syndromes that exclusively predispose to cutaneous SCC
None
Extreme photosensitivity and stark acceleration in the onset of skin cancer
Lack of nucleotide excision repair
Xeroderma pigmentosum
Subepidermal blistering, nonhealing wounds, high predisposition to SCC
Caused by loss-of-function mutations in COL7A1
Recessive dystrophic epidermolysis bullosa
Susceptibility to keratoacanthomas
Heterozygous germline inactivation of TGF-betaR1
Smith-Ferguson syndrome
_____ mutations occur at more than 70% frequency across all SCCs
TP53
_____ famiy genes are mutated in more than 70% of cutaneous SCC, 20% of oral head and neck SCC, 13% of lung SCC, and 10% of esophageal SCC
NOTCH
_____ amplication is a common lineage-specific driver of SCC
SOX2
Upregulation of _____ and _____ prheay signaling across the progression sequence of SCC development
ERK
mTOR (mammalian target of rapamycin)
BRAF inhibition used for
Melanoma
SMO inhibition used for
BCC
First FDA-approved BRAF inhibitor
Vemurafenib
More potent BRAF inhibitors less frequently observed adverse effects such as development of SCC and keratoacanthoma-like lesions
Dabrafenib
Encorafenib
The concomitant use of _____ with BRAF inhibitors almost completely suppress the emergence of SCCs
MEK
The long-term treatment of BCCs with the SMO inhibitor _____ has occasionally been associated with the evolution of treated tumors to a SCC morphology
Vismodegib